Engineers Gate Manager LP Homology Medicines, Inc. Transaction History

Engineers Gate Manager LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$2.6 - $4.17 $45,245 - $72,566	-17,402 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$3.64 - $7.78 $1,099 - $2,349	302 Added 1.77%	17,402 $63,000
Q3 2021 Nov 15, 2021	SELL	$6.01 - $8.71 $86,544 - $125,424	-14,400 Reduced 45.71%	17,100 $135,000
Q2 2021 Aug 16, 2021	BUY	$6.02 - $9.64 $48,160 - $77,120	8,000 Added 34.04%	31,500 $229,000
Q1 2021 May 17, 2021	BUY	$9.17 - $14.8 $215,495 - $347,800	23,500 New	23,500 $221,000

66.2K

Ticker FIXX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 57,402,000
Description
Homology Medicines, Inc., a genetic medicines company, focuses on transforming the lives of patients suffering from rare genetic diseases. Its proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a gene therapy or nucleas...

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

Stay updated on Engineers Gate Manager LP with notifications on news.